PAUL A. MAHON - 03 Oct 2024 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
EVP & GENERAL COUNSEL
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
03 Oct 2024
Net transactions value
-$3,051,356
Form type
4
Filing time
18 Oct 2024, 17:19:06 UTC
Previous filing
23 Sep 2024
Next filing
08 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $1,257,410 +7,700 +21% $163.30 44,410 03 Oct 2024 Direct F1, F2
transaction UTHR Common Stock Disposed to Issuer $2,695,539 -7,700 -17% $350.07 36,710 03 Oct 2024 Direct F1, F2
transaction UTHR Common Stock Options Exercise $1,257,410 +7,700 +21% $163.30 44,410 17 Oct 2024 Direct F2
transaction UTHR Common Stock Disposed to Issuer $2,870,637 -7,700 -17% $372.81 36,710 17 Oct 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -7,700 -9.2% $0.000000 75,850 03 Oct 2024 Common Stock 7,700 $163.30 Direct F1, F2, F3
transaction UTHR Share Tracking Award Options Exercise $0 -7,700 -10% $0.000000 68,150 17 Oct 2024 Common Stock 7,700 $163.30 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This STAP exercise for October 3, 2024 is being reported late due to an administrative error.
F2 This is an exercise of share tracking awards pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on June 20, 2024. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F3 Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.